Pathstone Holdings
AXSM icon

Pathstone Holdings’s Axsome Therapeutics AXSM Stock Holding History

Pathstone Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$572K Buy
3,384
+107
+3% +$18.5K ﹤0.01% 1689
2025
Q4 		$599K Sell
3,277
-522
-14% -$72.9K ﹤0.01% 1672
2025
Q3 		$461K Buy
3,799
+537
+16% +$60.5K ﹤0.01% 1810
2025
Q2 		$341K Buy
3,262
+10
+0.3% +$1.06K ﹤0.01% 1877
2025
Q1 		$379K Sell
3,252
-254
-7% -$28.9K ﹤0.01% 1845
2024
Q4 		$297K Sell
3,506
-337
-9% -$31K ﹤0.01% 1975
2024
Q3 		$345K Buy
3,843
+76
+2% +$6.63K ﹤0.01% 1911
2024
Q2 		$303K Sell
3,767
-54
-1% -$4K ﹤0.01% 1932
2024
Q1 		$305K Buy
3,821
+172
+5% +$14.4K ﹤0.01% 1940
2023
Q4 		$290K Buy
+3,649
New +$244K ﹤0.01% 1846

Other funds holding AXSM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return